BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 34502224)

  • 1. Mood Stabilizers in Psychiatric Disorders and Mechanisms Learnt from In Vitro Model Systems.
    Nayak R; Rosh I; Kustanovich I; Stern S
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurons derived from patients with bipolar disorder divide into intrinsically different sub-populations of neurons, predicting the patients' responsiveness to lithium.
    Stern S; Santos R; Marchetto MC; Mendes APD; Rouleau GA; Biesmans S; Wang QW; Yao J; Charnay P; Bang AG; Alda M; Gage FH
    Mol Psychiatry; 2018 Jun; 23(6):1453-1465. PubMed ID: 28242870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.
    Rybakowski JK
    CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mood stabilizers for patients with bipolar disorder: the state of the art.
    Altamura AC; Lietti L; Dobrea C; Benatti B; Arici C; Dell'Osso B
    Expert Rev Neurother; 2011 Jan; 11(1):85-99. PubMed ID: 21158558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficient LEF1 expression is associated with lithium resistance and hyperexcitability in neurons derived from bipolar disorder patients.
    Santos R; Linker SB; Stern S; Mendes APD; Shokhirev MN; Erikson G; Randolph-Moore L; Racha V; Kim Y; Kelsoe JR; Bang AG; Alda M; Marchetto MC; Gage FH
    Mol Psychiatry; 2021 Jun; 26(6):2440-2456. PubMed ID: 33398088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs, Stem Cells in Bipolar Disorder, and Lithium Therapeutic Approach.
    Coradduzza D; Garroni G; Congiargiu A; Balzano F; Cruciani S; Sedda S; Nivoli A; Maioli M
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials.
    Smith LA; Cornelius V; Warnock A; Bell A; Young AH
    Bipolar Disord; 2007 Jun; 9(4):394-412. PubMed ID: 17547586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of mood stabilizers on oxidative stress-induced cell death signaling pathways in the brains of rats subjected to the ouabain-induced animal model of mania: Mood stabilizers exert protective effects against ouabain-induced activation of the cell death pathway.
    Valvassori SS; Resende WR; Lopes-Borges J; Mariot E; Dal-Pont GC; Vitto MF; Luz G; de Souza CT; Quevedo J
    J Psychiatr Res; 2015 Jun; 65():63-70. PubMed ID: 25959616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical thickness and subcortical volumes alterations in euthymic bipolar I patients treated with different mood stabilizers.
    Li L; Ji E; Han X; Tang F; Bai Y; Peng D; Fang Y; Zhang S; Zhang Z; Yang H
    Brain Imaging Behav; 2019 Oct; 13(5):1255-1264. PubMed ID: 30145720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rapid suicide protection of mood stabilizers on patients with bipolar disorder: A nationwide observational cohort study in Taiwan.
    Tsai CJ; Cheng C; Chou PH; Lin CH; McInnis MG; Chang CL; Lan TH
    J Affect Disord; 2016 May; 196():71-7. PubMed ID: 26919054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patients.
    Hahn CG; Umapathy ; Wang HY; Koneru R; Levinson DF; Friedman E
    J Psychiatr Res; 2005 Jul; 39(4):355-63. PubMed ID: 16044535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing patterns of antidepressants, antipsychotics and mood stabilizers in bipolar patients misdiagnosed with major depressive disorder in China.
    Xiang YT; Hu C; Wang G; Zheng QW; Fang YR; Ungvari GS; Kilbourne AM; Lai KY; Si TM; Chen DF; Lu Z; Yang HC; Hu J; Chen ZY; Huang Y; Sun J; Wang XP; Li HC; Zhang JB; Chiu HF
    Hum Psychopharmacol; 2012 Nov; 27(6):626-31. PubMed ID: 23027671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological response in juvenile bipolar disorder subtypes: A naturalistic retrospective examination.
    Masi G; Perugi G; Millepiedi S; Mucci M; Pfanner C; Berloffa S; Pari C; Gagliano A; D'Amico F; Akiskal HS
    Psychiatry Res; 2010 May; 177(1-2):192-8. PubMed ID: 20381170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial comparing lithium plus valproic acid versus lithium plus carbamazepine in young patients with type 1 bipolar disorder: the LICAVAL study.
    Missio G; Moreno DH; Demetrio FN; Soeiro-de-Souza MG; Dos Santos Fernandes F; Barros VB; Moreno RA
    Trials; 2019 Oct; 20(1):608. PubMed ID: 31655626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mood stabilizers--past, present and future].
    Sümegi A
    Neuropsychopharmacol Hung; 2008 Mar; 10(1):31-42. PubMed ID: 18771018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.
    Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J
    Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction: the use of mood stabilizers in the treatment of psychiatric disorders.
    Bowden CL
    J Clin Psychiatry; 1999; 60 Suppl 5():3-4. PubMed ID: 10192401
    [No Abstract]   [Full Text] [Related]  

  • 18. Sodium butyrate and mood stabilizers block ouabain-induced hyperlocomotion and increase BDNF, NGF and GDNF levels in brain of Wistar rats.
    Varela RB; Valvassori SS; Lopes-Borges J; Mariot E; Dal-Pont GC; Amboni RT; Bianchini G; Quevedo J
    J Psychiatr Res; 2015 Feb; 61():114-21. PubMed ID: 25467060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium-associated transcriptional regulation of CRMP1 in patient-derived olfactory neurons and symptom changes in bipolar disorder.
    McLean CK; Narayan S; Lin SY; Rai N; Chung Y; Hipolito MS; Cascella NG; Nurnberger JI; Ishizuka K; Sawa AS; Nwulia EA
    Transl Psychiatry; 2018 Apr; 8(1):81. PubMed ID: 29666369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study.
    Lyoo IK; Dager SR; Kim JE; Yoon SJ; Friedman SD; Dunner DL; Renshaw PF
    Neuropsychopharmacology; 2010 Jul; 35(8):1743-50. PubMed ID: 20357761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.